The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022.
The total number of endoscopy procedures in Australia stood at 3.7 million in 2017. They are expected to grow at a CAGR of 6.5% during 2017-2022 to reach 5.1 million in 2022. While flexible endoscopy procedures accounted for 65.3% of the total procedural volume in 2017, the growth in volume will be equally driven by both rigid and flexible procedures growing at almost equal CAGRs of 6.2% and 6.7%, respectively, during 2017-2022.
Inpatient settings are still the ones taking up higher loads of endoscopic procedures in Australia, accounting for 67.8% of procedures in 2017. Hospitals are expected to dominate the procedural volumes during the forecast period, albeit at a continuously reducing share, accounting for 64.1% of total procedures in 2022, thus losing ground to outpatient and day care settings.
The higher share of hospital-based endoscopy, coupled with growing contribution from outpatient and day care based settings, has led to considerable opportunities for market participants from both end-user types. While hospitals, typically taking care of larger daily volumes, require sophisticated systems and workflow processes in place, day care centers are the ones with smaller volume requirements offering strategic alternatives to market participants in terms of smaller and more effective AER models.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...